Members of our premier management team were the pioneers in developing the life
science real estate industry.
With a proven track record for creating value, the BioMed Realty continues to leverage
its extensive expertise, experience and relationships with key leaders in the core
life science markets, having grown a portfolio that effectively meets the dynamic
needs of the life science industry.
Under the guidance and leadership of our experienced, highly knowledgeable management
team, BioMed Realty has grown from an initial asset base of $500 million in 2004 to over
$6 billion in life science assets, with properties throughout the seven life science
Denis J. Sullivan, Jr.
Executive Vice President & Chief Investment Officer
Denis J. Sullivan, Jr. has served as our Chief Investment Officer since December 2016, having previously served as Chief Financial Officer and various other senior positions in Finance and Acquisitions dating back to his joining the company in October of 2006. Mr. Sullivan was previously a member of the real estate investment banking group at Raymond James & Associates where he worked on the advisory of real estate clients related to public and private equity, mergers and acquisitions, and other services. Mr. Sullivan received a Master of Business Administration with honors from the Wharton School of the University of Pennsylvania and a Bachelor of Science in Aerospace Engineering from the University of Notre Dame.